ReviewNaunyn-Schmiedeberg's archives of pharmacology2022

Association and pharmacological synergism of the triple drug therapy baricitinib/remdesivir/rhACE2 for the management of COVID-19 infection.

Antonio Vitiello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.